Apostolos Zaravinos

European University Cyprus, Cyprus

  • Orcid: 0000-0003-4625-5562
  • Publications: 106
  • Citations: 2886
  • Keywords: Cancer Genetics; Cancer Genomics; Tumor Immunology; Translational Oncology; Viral Oncology; miRNAs; NGS
Short Bio
  • Dr. Apostolos Zaravinos is an Associate Professor of Cancer Genetics and coordinator of the program “BSc in Biological Sciences” in the Department of Life Sciences at the European University Cyprus. He is also the group leader of the “Cancer Genetics, Genomics & Systems Biology” group of the Basic and Translational Cancer Research Center (BTCRC). He received his B.Sc. in Biology from the Department of Biology, University of Crete, and his Ph.D. in Medicine from the Medical School of the same University. He worked as Research Scientist at the Harris Birthright Research Center for Fetal Medicine, King’s College Hospital, and performed postdoctoral research in Cancer Genetics at the Molecular Medicine Research Center, University of Cyprus. He completed his postdoctoral training in Immunogenetics and Cancer Genetics at the Department of Laboratory Medicine, Karolinska Institute. He also worked as Associate Professor in Genetics in the Department of Basic Medical Science, at the College of Medicine, Qatar University. Dr. Zaravinos holds two Specialisations: one in “Systems Biology” from the Systems Biology Center at Icahn School of Medicine, Mount Sinai, and another in “Genomic Data Science” from the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. He has worked as a Guest Editor for several Special Issues in scientific journals and as an Associate Faculty Member of the F1000Prime. In 2020 and 2021, he was included in the list of the top 2% of the world’s most-cited and influential in their main subfield discipline scholars, on a global list compiled by Stanford University. He is the recipient of the Science Award from the Youth Board of Cyprus, and the first Young Investigator Award from the Bank of Cyprus Oncology Centre. He is a member of the EACR, AACR, FEBS and an elected member of the Society of Biological Sciences in Cyprus (SBSCy) board. He has published >100 papers in refereed journals and 7 book chapters (h-index, 33; 2854 citations; source, Scopus). His research work aims towards the advanced understanding of carcinogenesis through the investigation of interactions across genes, the discovery of therapeutic targets, and the examination of the immune landscape in inflamed tumors.